MORGAN STANLEY PLC/CALL/CVS HEALTH/110/0.1/20.06.25 Share Price

Warrant

DE000MB92VS3

Market Closed - Börse Stuttgart 09:44:04 25/06/2024 pm IST
0.055 EUR -5.17% Intraday chart for MORGAN STANLEY PLC/CALL/CVS HEALTH/110/0.1/20.06.25
Current month+22.22%
1 month+61.76%
Date Price Change
25/24/25 0.055 -5.17%
24/24/24 0.058 +3.57%
21/24/21 0.056 -3.45%
20/24/20 0.058 +1.75%
19/24/19 0.057 +5.56%

Delayed Quote Börse Stuttgart

Last update June 25, 2024 at 09:44 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
Issuer Morgan Stanley
WKN MB92VS
ISINDE000MB92VS3
Date issued 21/07/2023
Strike 110 $
Maturity 20/06/2025 (360 Days)
Parity 10 : 1
Emission price 0.28
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.24
Lowest since issue 0.029
Spread 0.003
Spread %5.36%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
60.44 USD
Average target price
69.1 USD
Spread / Average Target
+14.32%
Consensus